SCHEMBL574330

SCHEMBL574330

CCCC(=O)Nc1cc(C(=O)OC)cc(S(=O)(=O)N=CN(C)C)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAPT P10636 4/20 0.36
▸ POLB P06746 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MDH1 P40925 3/20 0.35
▸ MDH2 P40926 3/20 0.35
▸ CDYL Q9Y232 1/20 0.34
▸ THRB P10828 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574329 1.00 LMNA (0.39) LMNAALDH1A1MEN1KMT2ACYP1A2
SCHEMBL574027 0.86 MAPT (0.40) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL574028 0.86 MAPT (0.40) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL11204853 0.81 ADORA2A (0.41) ALDH1A1MEN1KMT2ACYP1A2TSHR
SCHEMBL10224339 0.79 SMN1; SMN2 (0.38) LMNAALDH1A1MEN1KMT2ACYP1A2
SCHEMBL572903 0.78 KDM4E (0.38) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL572902 0.78 KDM4E (0.38) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL573292 0.75 VCAM1 (0.47) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL573293 0.75 VCAM1 (0.47) LMNAALDH1A1CYP1A2TSHRCYP2C19
SCHEMBL11542934 0.73 SMN1; SMN2 (0.56) LMNAALDH1A1KMT2ACYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback